DoW Toxic Exposures Clinical Trial Award
DoW Toxic Exposures Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 19 Nov 2026. Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or…
Opportunity overview
- Project name
- DoW Toxic Exposures Clinical Trial Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Toxic Exposures Clinical Trial Award?
DoW Toxic Exposures Clinical Trial Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 19 Nov 2026. Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or…
Who is funding DoW Toxic Exposures Clinical Trial Award?
DoW Toxic Exposures Clinical Trial Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Toxic Exposures Clinical Trial Award?
The application deadline is 19 Nov 2026 00:00 (UTC).
Where will the DoW Toxic Exposures Clinical Trial Award project take place?
The project location(s) are: United States.
How can I apply for DoW Toxic Exposures Clinical Trial Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.